Concord Drugs Ltd - 538965 - Financial Results For Q1 JUNE 2024
Financial Results for Q1, JUNE 202412-09-2024
12-09-2024
Concord Drugs Ltd - 538965 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication regarding 29th AGM Notice that to be held on 30.09.2024 at 09:45 AM.10-09-2024
Concord Drugs Ltd - 538965 - Reg. 34 (1) Annual Report.
Annual report for year 2023-2024.06-09-2024
Concord Drugs Ltd - 538965 - Book Closure.
Book Closure for purpose of 29th AGM Shall be from 24.09.2024 to 30.09.2024 (both dates Inclusive)06-09-2024
Concord Drugs Ltd - 538965 - Annual General Meeting To Be Held On 30.09.2024
29th Annual general Meeting to be held on 30.09.2024 at 09:45 Am .06-09-2024
Concord Drugs Ltd - 538965 - Board Meeting Outcome for Outcome Of Board Meeting
Out Come of Board Meeting .06-09-2024
Concord Drugs Ltd - 538965 - Board Meeting Intimation for Meeting To Be Held On 06.09.2024.
Concord Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/09/2024 ,inter alia, to consider and approve Increase in Authorized Capital, Proposal for Issue of Preferential Issue of Shares, Other business if any.02-09-2024
Concord Drugs Ltd - 538965 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed newspaper publication on the Unaudited (Standalone and Consolidated) financial results for quarter ended 30th June 2024.11-08-2024
Concord Drugs Ltd - 538965 - Re-Submission Of Financial Results For Year/Quarter Ended 31.03.2024
Submission of financial results for year/quarter ended 31.03.2024 after rectification .09-08-2024
Concord Drugs Ltd - 538965 - Board Meeting Outcome for Outcome Of Board Meeting
Submission of Financial Results for Quarter ended 30.06.202409-08-2024